title: Comparison of neoral and sandimmun cyclosporines for de novo lung transplantation in cystic fibrosis patients.
authors.affiliation: Imperial College School of Medicine, Harefield Hospital, United Kingdom.
authors.forename: G
authors.initials: G
authors.lastname: Mikhail
authors.forename: H
authors.initials: H
authors.lastname: Eadon
authors.forename: N
authors.initials: N
authors.lastname: Leaver
authors.forename: A
authors.initials: A
authors.lastname: Khaghani
authors.forename: M
authors.initials: M
authors.lastname: Yacoub
authors.forename: N
authors.initials: N
authors.lastname: Banner
mesh_terms: D000284:Administration, Oral; D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003550:Cystic Fibrosis / Q000150:complications / Q000601:surgery*; D005260:Female; D005541:Forced Expiratory Volume; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use; D016040:Lung Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D012131:Respiratory Insufficiency / Q000209:etiology / Q000601:surgery*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine